Search hospitals > Wisconsin > Milwaukee
Aurora Saint Luke's Medical Center
Claim this profileMilwaukee, Wisconsin 53215
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Adenocarcinoma
Conducts research for Recurrence
459 reported clinical trials
39 medical researchers
Summary
Aurora Saint Luke's Medical Center is a medical facility located in Milwaukee, Wisconsin. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Adenocarcinoma, Recurrence and other specialties. Aurora Saint Luke's Medical Center is involved with conducting 459 clinical trials across 544 conditions. There are 39 research doctors associated with this hospital, such as Rubina Qamar, Thomas J. Saphner, Antony Ruggeri, and Michael A Thompson.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderHER2 negative
ER positive
HER2 positive
Top PIs
Rubina QamarAurora Saint Luke's Medical Center1 year of reported clinical research
Expert in Breast Cancer
Expert in Cancer
26 reported clinical trials
72 drugs studied
Thomas J. SaphnerAurora Saint Luke's Medical Center4 years of reported clinical research
Expert in Cancer
Studies Breast Cancer
27 reported clinical trials
57 drugs studied
Antony RuggeriAurora Cancer Care-Milwaukee West4 years of reported clinical research
Studies Cancer
Studies Solid Tumors
14 reported clinical trials
57 drugs studied
Michael A ThompsonAurora Cancer Care-Milwaukee West3 years of reported clinical research
Studies Multiple Myeloma
Studies Plasma Cell Neoplasms
12 reported clinical trials
29 drugs studied
Clinical Trials running at Aurora Saint Luke's Medical Center
Breast Cancer
Cancer
Non-Small Cell Lung Cancer
Prostate Cancer
Lung Cancer
Bladder Carcinoma
Renal Cell Carcinoma
Ovarian Cancer
Rectal Cancer
Bladder Cancer
Hormone Therapy with or without Radiation
for Breast Cancer
This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Durvalumab + Chemotherapy
for Breast Cancer
This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint Ultrahigh (MP2) stage II-III hormone receptor positive, HER2 negative breast cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as paclitaxel, doxorubicin, and cyclophosphamide work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. There is some evidence from previous clinical trials that people who have a MammaPrint Ultrahigh Risk result may be more likely to respond to chemotherapy and immunotherapy. Adding durvalumab to usual chemotherapy may be able to prevent the cancer from returning for patients with MP2 stage II-III hormone receptor positive, HER2 negative breast cancer.
Recruiting2 awards Phase 340 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Aurora Saint Luke's Medical Center?
Aurora Saint Luke's Medical Center is a medical facility located in Milwaukee, Wisconsin. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Adenocarcinoma, Recurrence and other specialties. Aurora Saint Luke's Medical Center is involved with conducting 459 clinical trials across 544 conditions. There are 39 research doctors associated with this hospital, such as Rubina Qamar, Thomas J. Saphner, Antony Ruggeri, and Michael A Thompson.
Where is Aurora Saint Luke's Medical Center located?
**Aurora St. Luke's Medical Center**
- **Address:** 2900 W Oklahoma Ave, Milwaukee, WI 53215
- **Directions:** From I-43 N, take the I-94 E exit. Continue on I-94 E to W Oklahoma Ave in Milwaukee. Take exit 309B from I-94 E, and the hospital will be on your left.
Who should I call to ask about financial aid or insurance network?
For financial assistance at Aurora Saint Luke's Medical Center, contact Aurora Health Care at 800-326-2250 or visit [www.aurorahealthcare.org/patient-visitors/billing-payment/financial-assistance](http://www.aurorahealthcare.org/patient-visitors/billing-payment/financial-assistance). For insurance inquiries, call 833-528-7672 or visit [www.advocateaurorahealth.org/contact-us/](http://www.advocateaurorahealth.org/contact-us/).
What insurance does Aurora Saint Luke's Medical Center accept?
Aurora Saint Luke's Medical Center accepts a wide range of insurance plans, such as Medicare, in-state Medicaid, Tricare, and Blue Cross/Blue Shield, among others. It is crucial to confirm with your insurance provider that St. Luke's is in-network and your plan covers the intended services.
What awards or recognition has Aurora Saint Luke's Medical Center received?
**Aurora Saint Luke's Medical Center, Milwaukee, Wisconsin**
- Recognized for research excellence, notably at the eighth annual Research Recognition Event.
- Contributed to significant studies, including two heart valve replacement studies with encouraging results.
- Achieved Magnet recognition, underscoring a commitment to nursing excellence and high-quality patient care.